Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...
The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...
1yon MSN
Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests
After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.
Credit: Getty Images In men with a total PSA of 2 ng/mL or more, a low percent-free PSA value is associated with a greater likelihood of clinically significant prostate cancer. Adding percent-free PSA ...
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...
Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...
February 10, 2023 – Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results